Updated
UltragenyxRARE · Healthcare
$15.43-0.90%
Market cap$1.6B
IndustryBiotechnology

Ultragenyx (RARE) Superinvestor holders

14 of the superinvestors we track hold Ultragenyx (RARE) in their latest 13F filings, $589M in total.

Summary

The largest holder is Cliff Asness (AQR Capital Management), with $214M, 0.1% of the portfolio.

In their latest quarter: 6 added, 7 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Cliff Asness
AQR Capital Management
Added 6,560,809$214M 0.1%Q2 2026
Two Sigma
Two Sigma Investments
Added 3,621,200$121M 0.1%Q2 2026
Frank Sands
Sands Capital Management
Trimmed 3,158,368$105M 0.4%Q2 2026
David Shaw
D. E. Shaw & Co.
Added 1,730,193$58M 0.0%Q2 2026
David Vogel
Voloridge Investment Management
Trimmed 1,241,556$41M 0.2%Q2 2026
Jim Simons
Renaissance Technologies
Trimmed 413,700$14M 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Added 290,818$10M 0.0%Q2 2026
Man Group
Man Group plc
Trimmed 195,110$7M 0.0%Q2 2026
Paul Marshall
Marshall Wace
Added 159,889$5M 0.0%Q2 2026
Alger
Fred Alger Management
Trimmed 143,155$5M 0.0%Q2 2026
Louis Bacon
Moore Capital Management
Trimmed 128,035$4M 0.1%Q2 2026
Alan Howard
Brevan Howard
Trimmed 102,768$3M 0.1%Q2 2026
Acadian
Acadian Asset Management
Added 61,748$924,000 0.0%Q3 2026
Peter Muller
PDT Partners
Held 15,405$514,373 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202614
Q1 202616
Q4 202516
Q3 202521
Q2 202521
Q1 202521
Q4 202421
Q3 202423

Questions about Ultragenyx

Which superinvestors own Ultragenyx?

14 of the superinvestors we track hold Ultragenyx (RARE) in their latest 13F filings, $589M in total. Cliff Asness, Two Sigma, Frank Sands, David Shaw, David Vogel, Jim Simons.

Who is the largest superinvestor holder of RARE?

The largest holder is Cliff Asness (AQR Capital Management), with $214M, 0.1% of the portfolio.

From Ultragenyx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Ultragenyx and thousands of other companies, in one place. Free to start.